Roche diagnostics corp:1106277 [15-023310]
Ended Awarded Last action
- Contract number
- HHSN26100012
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,600
Award facts
- Contract value 100% obligated
- $1,600.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$2,464 | |
| Original award | $4,064 |
About this award
Roche Diagnostics Corporation was awarded a Blanket Purchase Agreement (BPA) call contract by the National Cancer Institute with a ceiling value of $1,600.00. The contract, which commenced on February 18, 2015, and concluded on January 31, 2017, is structured as a firm fixed price procurement with no set-aside designation. This BPA call represents a child contract vehicle, likely issued under a larger General Services Administration Schedule agreement, enabling the National Cancer Institute to acquire diagnostic products and services from Roche's established pricing and terms.
As a global leader in in vitro diagnostics and laboratory instrumentation, Roche Diagnostics Corporation supplied diagnostic solutions to support the National Cancer Institute's medical research and clinical testing requirements at the Bethesda, Maryland location. The company's federal contracting portfolio demonstrates extensive experience providing molecular diagnostic testing equipment, clinical chemistry analyzers, immunochemistry systems, reagents, and specialized diagnostic services across federal healthcare agencies. This award reflects Roche's continued participation in the competitive federal marketplace, delivering advanced medical diagnostic technologies to support the National Institutes of Health's cancer research and clinical mission.
Quick answers
Who was awarded contract HHSN26100012?
HHSN26100012 was awarded to Roche Diagnostics Corporation by National Cancer Institute (National Institutes of Health) on February 18, 2015.
How much is contract HHSN26100012 worth?
The government has obligated $1,600 on HHSN26100012.
Is contract HHSN26100012 an order under another contract?
Yes. HHSN26100012 is a BPA call under HHSN263200400060630B, a blanket purchase agreement.
Was contract HHSN26100012 competed?
The extent of competition for HHSN26100012 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award